Publications by authors named "Terry Hawrysh"

Claim this Profile
P
Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: "It's About Time we Bring Trials to People".
Dawn P Richards, John Queenan, Linnea Aasen-Johnston, Heather Douglas, Terry Hawrysh

Ther Innov Regul Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review.
Kednapa Thavorn, Emily Rose Thompson, Srishti Kumar, Aliisa Heiskanen, Anubhav Agarwal, Terry Hawrysh

Value Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
Natasha Kekre, Kevin A Hay, John R Webb, Ranjeeta Mallick, Miruna Balasundaram, Terry Hawrysh

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience.
Mackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, Ian D Graham, Harold Atkins

Pharmacoeconomics· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a Platform for Meaningful Patient Partnership to Accelerate "Bench-to-Bedside" Translation of Promising New Therapies.
Grace Fox, Dean A Fergusson, Madison Foster, Terry Hawrysh, Stefany Dupont

Healthc Q· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy.
Mackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, Ian D Graham, Harold Atkins

BMJ Open· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.
Gisell Castillo, Manoj M Lalu, Sarah Asad, Madison Foster, Natasha Kekre, Terry Hawrysh

BMJ Open· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.
Gisell Castillo, Manoj Lalu, Sarah Asad, Madison Foster, Natasha Kekre, Terry Hawrysh

Trials· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a preoperative personalized risk communication tool: a prospective before-and-after study.
Emily Hladkowicz, David Yachnin, Laura Boland, Kumanan Wilson, Annette McKinnon, Kira Hawrysh, Terry Hawrysh

Can J Anaesth· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.
Madison Foster, Dean A Fergusson, Terry Hawrysh, Justin Presseau, Natasha Kekre

Res Involv Engagem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis